Nanalysis Scientific Corp.
NSCIF
$0.11
$0.0112.66%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 90.18% | 9.65% | -5.20% | 51.32% | -167.15% |
| Total Depreciation and Amortization | 118.53% | -74.42% | -68.98% | -72.11% | 1.38% |
| Total Amortization of Deferred Charges | -89.90% | -- | -- | -- | 0.37% |
| Total Other Non-Cash Items | -89.60% | -81.25% | -63.57% | -42.79% | 682.41% |
| Change in Net Operating Assets | 366.22% | 116.42% | -202.99% | 22.03% | 62.74% |
| Cash from Operations | 149.40% | 5.28% | -246.99% | 71.90% | 140.65% |
| Capital Expenditure | -- | -493.18% | -8,885.71% | -3.58% | 100.00% |
| Sale of Property, Plant, and Equipment | -73.06% | -96.17% | 83.59% | -- | 11,128.57% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -15.08% | 25.96% | 30.76% | 4.99% | 69.05% |
| Cash from Investing | -98.26% | 13.91% | 21.05% | 5.90% | 80.61% |
| Total Debt Issued | 21.97% | -22.64% | -- | -- | -132.35% |
| Total Debt Repaid | -119.63% | 103.30% | 85.75% | 35.28% | 211.85% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -10.81% | 9.52% | 3.66% | 40.37% | 77.39% |
| Cash from Financing | 76.24% | 511.38% | 234.81% | -5,415.15% | -90.21% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 139.31% | 107.23% | 36.79% | -167.21% | 318.89% |